Honeycomb Core Materials Market Size, Trend, End-Use Industry, Regional Demand, Forecasts
Honeycomb Core Materials Market Size, Trend, End-Use Industry, Regional Demand, Forecasts | $4.6 billion by 2030
Stay updated with breaking news from Corinth Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Honeycomb Core Materials Market Size, Trend, End-Use Industry, Regional Demand, Forecasts | $4.6 billion by 2030
Honeycomb Core Materials Market Size, Trend, End-Use Industry, Regional Demand, Forecasts | $4.6 billion by 2030
Morepen Laboratories yesterday approved incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the company. The members approved the issue and allotment of 58.50 million equity shares for cash to Corinth Investment Holdings AG, Switzerland (www.corinthinvest.com) at Rs.41.60 per share aggregating to RS. 243.36 crore. Shareholders also approved 50 million fully convertible warrants a promoter group company Liquid Holdings at Rs.38 per warrant/ share aggregating up to Rs. 190 crore for cash to be converted into equity within 18 months. This is a milestone for the...
New Delhi: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), a leading manufacturer of high-quality APIs, Home Diagnostics, Formulations and OTC products, yesterday approved incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the company. The members approved the issue and allotment of 58.50 million equity shares for cash to Corinth Investment Holdings AG, Switzerland (www.corinthinvest.com) at Rs.41.60 per share aggregating to Rs. 243.36 crores. Shareholders also approved 50 million fully convertible warrants to a promoter group company Liquid...
ADVERTISEMENT Indian Drugmaker Morepen Nabs $100M From Corinth Group Law360 (May 21, 2021, 1:47 PM EDT) -- Private investment firm Corinth Group has agreed to plug $100 million into India-based pharmaceutical company Morepen Group, which will use the capital to boost its research and development capabilities and build new facilities, the companies said Friday. The agreement sees Switzerland-headquartered Corinth paying $32.5 million for 58.50 million equity shares in Morepen Laboratories Ltd., which is equivalent to a 9.31% equity stake, according to a statement. As part of the deal, the inv...